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The year 2000 is poised to be declared
the ‘Year of the Genome’. The
sequences of human chromosomes 21
and 22 have been published in the
past six months, and two further
landmark announcements are
expected within days — indeed, may
even have been made by the time
you read this. Scientists of the Human
Genome Project are on the verge of
announcing completion of a “rough
draft” of the human genome. And the
world should soon hear another
stunning proclamation from Celera
Genomics, which recently completed
a genome draft and is now assembling
its data into near-final form.
But amid all the bluster about
who will deliver the sequence first,
there’s been little attention paid to
the quality and completeness of the
data we’ll have after the sensational
announcements are made and the
hoopla’s died down. What, for
instance, is meant by a ‘rough draft’?
The rough draft from the Human
Genome Project — an international
consortium of labs funded primarily
by the US government and the UK’s
Wellcome Trust — will sequence
90% of the roughly 3.2 billion bases
of the human genome. Celera says its
soon-to-be-finished product (for
which it is also using the
public-domain data) will be 99%
complete. The criteria for completion
of these stages are arbitrary.
Finishing the job will be the hardest
part, a matter of diminishing returns,
and 1–3 years may be needed to
tackle those remaining percentage
points by closing the thousands of
gaps in the sequence.
Which raises the question: Are
the not-quite-finished data we’re
about to see reliable, and useful for
biomedical research? Or are the
numerous gaps in the sequence a
tiny problem with huge effects?
In answering these questions, it’s
important to know why the gaps exist
at all. There are two types of gap: one
is a statistical artifact, the other is
biologically meaningful. Statistical
gaps are a byproduct of the
‘shotgunning’ sequencing methods
used by both the public and private
efforts. DNA is chopped up into
small pieces randomly, and the pieces
are sequenced enough times to cover
any particular point on the genome
several times over, on average.
Computer programs then search for
overlap among the sequences and
connect and order the fragments into
a linear whole. By chance, some
stretches will be covered many times
over, whereas others will be missed
completely; the more sequencing, the
fewer gaps will remain.
What exactly is meant by a ‘rough
draft’ of the human genome?
The second type of gap occurs when
a stretch of DNA refuses to
cooperate with the sequencing
techniques. It may be incompatible
with the bacterial cloning agent and
not get cloned. It may throw off the
sequencing enzymes because of a
highly biased composition of bases.
Or it may consist of multiple
repeated segments, which can be
difficult to sequence and can confuse
computer programs trying to piece
together the fragments.
Statistical gaps are closed during
the ‘finishing process’ simply by
doing more shotgun
sequencing — but in a
directed manner, aiming
efforts at regions in
which gaps occur.
The bits of DNA
that are resistant to
sequencing are more
troublesome, and
require creative
thinking as
technicians test various conditions to
try to coax out the recalcitrant DNA.
“We won’t give up until a number of
things have been tried, and we will
try hard,” says Richard Myers,
director of Stanford University’s
Human Genome Sequencing Center.
But Myers and others concede
that some stretches of DNA may
never be sequenced, and at some
point the heads of labs with the
painstaking, less glamorous task of
‘finishing’ may need to bow to the
diminishing returns curve. The
public consortium’s criterion for
finishing is to obtain sequence that’s
99.99% complete and accurate. The
‘finished’ sequence of human
chromosome 22 published last
December contained only 11 gaps,
and that of chromosome 21
published last month had only 10,
and was judged 99.7% complete.
But do the gaps matter? Most
researchers now desiring genomic
data want to use it to recognize
particular genes of interest, and for
this, the public-domain 90%
rough-draft data (and certainly any
more-complete data from Celera)
should work quite well. A jigsaw
puzzle missing a few pieces still gives
us most of the picture, and
incomplete sequence data do give
labs a jump on researching genes and
developing applications. In fact, for
several years researchers have been
using human genome data now being
added daily to the GenBank
repository. The Human Genome
Project sequencers say this is
precisely the reason they decided to
make unpublished sequence available
via GenBank.
But for other purposes,
a gap-ridden data set might
not be good enough.
Because regulatory
regions may be physically
distant from transcribed
regions of genes, their
likelihood of being
separated by a gap is
greater. So researchers
interested in gene
regulation may want to
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wait for the final product. The same
goes for those studying gene clusters,
exploring non-coding regions, or
comparing sequence divergence
across species. For some studies of
regulation, however, comparative data
from the expected rapid sequencing
of other organisms could help
compensate for a lack of complete
human data, points out Jane Rogers,
human sequencing and mapping
project manager for the Sanger Centre
in Cambridge, UK.
Most gaps may be irrelevant to
researchers interested in gene
function, as many — in particular,
repetitive sequences — are thought
to comprise non-coding and/or
non-functional regions. The genomic
sequence of the fruit fly, published
in March, suggests this could be the
case; although the sequence
contained gaps, virtually all of the
2,783 genes previously described in
this model organism were found in
the sequence.
Indeed, some say filling in gaps
should be the least of our concerns.
More important than filling a gap is
‘capturing’ a gap — determining the
order and orientation of sequence on
either side of it, so the gap can be
located and its size determined,
according to Elbert Branscomb, who
directs the Joint Genome Institute of
the University of California’s
Lawrence Livermore National
Laboratory. As a stubborn gap will
probably be non-coding, it might not
be important to determine its exact
sequence. The fact that most of the
public data are not yet ordered and
oriented poses limitations on their
immediate use, so the first stage in the
Human Genome Project’s finishing
process may need to be ordering and
orienting the countless stretches of
DNA residing in GenBank. Celera’s
whole-genome shotgunning approach
and subsequent one-fell-swoop
assembly, and its use of
public-domain data, should produce
ordered and oriented sequence.
Both efforts say they are
committed to the nitty-gritty work of
the finishing process. Although some
observers expect Celera’s commercial
interests may lead it to quit early and
move on, the public team seems
resolute about finishing. Too much
so, in the eyes of some. The public
effort, Branscomb says, is trying “to
soldier on and beat every last gap out
of existence… It’s a matter of taste
and judgement just how far down
that Puritan road you want to go.”
Shall we soldier on and beat
every last gap out of existence?
David Lipman, director of the
National Center for Biotechnology
Information, echoes such concerns.
“This notion of being ‘totally
complete’ to me is problematical and
not that meaningful,” he says. “My
view of completion is more one
based on utility.” Others agree,
arguing that gap closure should be
selective, prioritizing regions of
greatest functional interest.
As for Celera, chief scientist
Eugene Myers says it won’t abandon
the human genome “until we’re
satisfied we have a version of
substantial utility.” The concept of
being ‘finished’, he stresses, is
different for a complex eukaryote
whose entire genome may not be
accessible with current methods than
for a prokaryote whose simpler
genome is.
In the meantime, both public and
private efforts are already leaping to
the next steps — ordering and
orienting sequence; identifying and
ascribing functions to genes; and
sequencing variations on the human
theme, cataloging the single-base
differences that sometimes may help
determine an individual’s
predisposition for disease. In
addition, many labs are actively
sequencing the genomes of other
organisms for comparative purposes
— most immediately, the mouse.
Even if the two sides were to fill
all the gaps and proclaim 100%
completion, however, that still would
not mean every base in the human
genome had been sequenced.
Sequencing techniques to date are
well able to sample DNA only from
the ‘euchromatic’ portion of the
genome, and not from the largely
repetitive and non-coding
‘heterochromatic’ region. This is not
much of a loss to those interested in
finding genes and in questions of
functionality — except that growing
evidence indicates that
heterochromatic regions do contain
some genes, although they contain
fewer of them and express them at
lower levels. “Skipping
heterochromatin altogether is not a
good thing,” says Richard Wilson,
co-director of the Human Genome
Sequencing Center at Washington
University, St Louis.
Regardless, the data being
presented by Celera and by the
Human Genome Project this year are
rightly recognized as a highly useful
achievement, even in their
not-quite-complete state. The
much-trumpeted antagonism
between the public and private
efforts is now being downplayed by
both sides as they recognize their
approaches as complementary and
somewhat mutually beneficial — and
as researchers become excited over
seeing light at the end of the tunnel.
Of course, obtaining a full human
genome sequence is just the first
step in a long and complex process.
“It’s a little bit like a new continent,
the human genome, being explored
by the Dutch East India Company
on one hand and the US Geological
Survey on the other,” says Harold
Varmus, former head of the National
Institutes of Health. “They’re each
measuring the coast line. Some parts
are fogged in; they can’t see them.”
But what will matter in the long run,
Varmus says, is “the map that’s
produced and then, most important
of all, what the miners do when they
get there — who gets the interesting
information out of the continent.”
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